-
Mashup Score: 0Africa's Road to Zero Polio - 4 month(s) ago
The recently announced Africa Regional Polio Eradication Action Plan 2024-2025 outlines a new strategy for responding to polio outbreaks. Released on August 19, 2024, the pre-publication version introduces a different approach by addressing all instances of poliomyelitis (polio) transmission, including outbreaks of circulating variant poliovirus, as if they were cases of wild poliovirus (WPV).
Source: www.precisionvaccinations.comCategories: General Medicine News, Infectious DiseaseTweet
-
Mashup Score: 0World's Largest Vaccine Producer Partners With Mpox Vaccine - 5 month(s) ago
Tonix Pharmaceuticals Holding Corp. and Bilthoven Biologicals (BBio) today announced a collaboration to advance TNX-801, a mpox vaccine candidate. TNX-801 (recombinant horsepox virus) is a live replicating, attenuated, single-dose vaccine candidate based on horsepox in preclinical development to prevent mpox and smallpox. TNX-801 is based on technology that has the potential to be used as a viral vector platform from which recombinant versions can be developed to protect against other infectious diseases.
Source: www.precisionvaccinations.comCategories: General Medicine News, Infectious DiseaseTweet-
“TNX-801 (recombinant horsepox virus) is a live replicating, attenuated, single-dose vaccine candidate based on horsepox in preclinical development to prevent mpox and smallpox.” https://t.co/KGDn9tJxeP
-
-
Mashup Score: 0194 Pediatric Influenza Fatalities Surpass Previous Flu Seasons - 5 month(s) ago
Nine trivalent influenza vaccines are offered in the United States
Source: www.precisionvaccinations.comCategories: General Medicine News, Infectious DiseaseTweet-
“This data exceeds the National Center for Health Statistics Mortality Surveillance (NCHS) data reported for the previous three flu seasons: 186, 49, and 1.” https://t.co/io9WsAV7r4
-
-
Mashup Score: 0Gates Grants $3,800,000 to Develop Ready-to-Use mRNA RSV Vaccine - 5 month(s) ago
Immorna Biotherapeutics Inc. today announced that it has received a $3.8 million grant from the Bill & Melinda Gates Foundation to support the clinical development of JCXH-108. JCXH-108 is a Respiratory Syncytial Virus (RSV) monovalent vaccine candidate based on Immorna’s proprietary mRNA and ‘Ready-to-Use’ lipid nanoparticle technologies.
Source: www.precisionvaccinations.comCategories: General Medicine News, Infectious DiseaseTweet-
“JCXH-108 is a Respiratory Syncytial Virus (RSV) monovalent vaccine candidate based on Immorna’s proprietary mRNA and ‘Ready-to-Use’ lipid nanoparticle technologies.” https://t.co/jrVA3OwoPv
-
-
Mashup Score: 0Sao Paulo Brazil Quietly Becomes Chikungunya Hot-Spot - 5 month(s) ago
Chikungunya disease travel vaccine is approved and available in 2024
Source: www.precisionvaccinations.comCategories: General Medicine News, Infectious DiseaseTweet-
“The Municipality of São Paulo's Health Surveillance Coordination of the Health Department reported in mid-August that 29 locally acquired and 40 imported Chikungyna cases have occurred this year.” https://t.co/Ly133c9FNz
-
-
Mashup Score: 6RSV Detections Can be Deceiving - 5 month(s) ago
Pharmacies offer RSV vaccines in 2024
Source: www.precisionvaccinations.comCategories: General Medicine News, Infectious DiseaseTweet-
“ RSV circulation in the U.S. usually begins in Florida and then migrates to the southeast and later to the north and west regions.” https://t.co/V7IPW2vUl6
-
-
Mashup Score: 111 Oropouche Fever Cases Diagnosed in Florida - 5 month(s) ago
Throughout 2024, Cuba has been grappling with an outbreak of Oropouche Fever. And now, its western neighbor, the United States, has started to report cases related to travelers from Cuba. The Florida Department of Health (FDH) has recently reported 11 Oropouche Fever cases. As of August 10, 2024, these Florida cases had their onset in 2024 and were found in individuals who had traveled to Cuba two weeks before showing symptoms.
Source: www.precisionvaccinations.comCategories: General Medicine News, Infectious DiseaseTweet-
“The Oropouche reported cases were found in the following Florida counties: Hillsborough (4), Lee (2), Miami-Dade (1), Orange (2), and Polk (2).” https://t.co/kYGPg8VpBT
-
-
Mashup Score: 0
Avian influenza mortality might be due to a H5N1 virus pneumonia
Source: www.precisionvaccinations.comCategories: General Medicine News, Infectious DiseaseTweet-
“Even if mortality were lower due to receptor switching, widespread transmission could still lead to a substantial healthcare burden and morbidity and mortality due to potentially high numbers of concurrent cases.” https://t.co/HECv3ejnvp
-
-
Mashup Score: 0Nine Infants Died During U.K. Whooping Cough Outbreak - 6 month(s) ago
New data published today by the UK Health Security Agency (UKHSA) shows whooping cough cases continue to increase in England, reaching 7,599 at the end of May 2024. On July 11, 2024, the UKHSA also confirmed there have been nine infant deaths since the current whooping cough (pertussis) outbreak began in November last year. Whooping cough is a cyclical disease that peaks every 3 to 5 years. The last cyclical increase in England occurred in 2016.
Source: www.precisionvaccinations.comCategories: General Medicine News, Infectious DiseaseTweet-
“The latest uptake data for the vaccination offered to pregnant women to protect newborn infants against whooping cough continues to decline, with coverage at 58.9% in March 2024 compared to the peak coverage (72.6%) in March 2017.” https://t.co/ZDIWz3dhaW
-
-
Mashup Score: 0First Cell-based Trivalent Flu Shots Ship in the USA - 6 month(s) ago
CSL Seqirus today announced that it has commenced shipping its differentiated portfolio of influenza vaccines. This year, the company’s influenza vaccines are being produced as trivalent influenza vaccine formulations, in compliance with the U.S. Food and Drug Administration’s directive in 2024 to remove the B/Yamagata strain. For the 2024-2025 influenza vaccine portfolio, CSL Seqirus is the leading manufacturer offering a differentiated influenza vaccine option approved for use in people six months and older.
Source: www.precisionvaccinations.comCategories: General Medicine News, Infectious DiseaseTweet-
“This year, the company's influenza vaccines are being produced as trivalent influenza vaccine formulations, in compliance with the U.S. Food and Drug Administration's directive in 2024 to remove the B/Yamagata strain.” https://t.co/aDXoQkfxQM
-
“This action plan advocates for a more proactive strategy instead of..It suggests that countries affected by polio should conduct between three and five vaccination campaign rounds based on their specific risk and population immunity.” https://t.co/E0EJbvBfO7